{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T05:19:26Z","timestamp":1785734366526,"version":"3.56.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T00:00:00Z","timestamp":1731888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T00:00:00Z","timestamp":1731888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cytotechnology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s10616-024-00669-4","type":"journal-article","created":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T11:30:26Z","timestamp":1731929426000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Enhancing monoclonal antibody production efficiency using CHO-MK cells and specific media in a conventional fed-batch culture"],"prefix":"10.1007","volume":"77","author":[{"given":"Hisashi","family":"Saeki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaori","family":"Fueki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,18]]},"reference":[{"key":"669_CR1","doi-asserted-by":"publisher","first-page":"3290","DOI":"10.3390\/ijms22073290","volume":"22","author":"S Alhuthali","year":"2021","unstructured":"Alhuthali S, Kotidis P, Kontoravdi C (2021) Osmolality effects on CHO cell growth, cell volume, antibody productivity and glycosylation. Int J Mol Sci 22:3290. https:\/\/doi.org\/10.3390\/ijms22073290","journal-title":"Int J Mol Sci"},{"issue":"4","key":"669_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/biot.201800352","volume":"14","author":"AS Ali","year":"2019","unstructured":"Ali AS, Raju R, Kshirsagar R, Ivanov AR, Gilbert A, Zang L, Karger BL (2019) Multi-omics study on the impact of cysteine feed level on cell viability and mAb production in a CHO bioprocess. Biotechnol J 14(4):e1800352. https:\/\/doi.org\/10.1002\/biot.201800352","journal-title":"Biotechnol J"},{"issue":"8","key":"669_CR3","doi-asserted-by":"publisher","first-page":"e1900565","DOI":"10.1002\/biot.201900565","volume":"15","author":"AS Ali","year":"2020","unstructured":"Ali AS, Chen R, Raju R, Kshirsagar R, Gilbert A, Zang L, Karger BL, Ivanov AR (2020) Multi-omics reveals impact of cysteine feed concentration and resulting redox imbalance on cellular energy metabolism and specific productivity in CHO cell bioprocessing. Biotechnol J 15(8):e1900565. https:\/\/doi.org\/10.1002\/biot.201900565","journal-title":"Biotechnol J"},{"issue":"4","key":"669_CR4","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1016\/j.biotechadv.2018.04.011","volume":"36","author":"JM Bielser","year":"2018","unstructured":"Bielser JM, Wolf M, Souquet J, Broly H, Morbidelli M (2018) Perfusion mammalian cell culture for recombinant protein manufacturing\u2014a critical review. Biotechnol Adv Jul-Aug 36(4):1328\u20131340. https:\/\/doi.org\/10.1016\/j.biotechadv.2018.04.011","journal-title":"Biotechnol Adv Jul-Aug"},{"key":"669_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.biotechadv.2021.107757","volume":"49","author":"L Bryan","year":"2021","unstructured":"Bryan L, Clynes M, Meleady P (2021) The emerging role of cellular post-translational modifications in modulating growth and productivity of recombinant Chinese hamster ovary cells. Biotechnol Adv Jul-Aug 49:107757. https:\/\/doi.org\/10.1016\/j.biotechadv.2021.107757","journal-title":"Biotechnol Adv Jul-Aug"},{"key":"669_CR6","doi-asserted-by":"publisher","unstructured":"Castelli MS, McGonigle P, Hornby PJ (2019) The pharmacology and therapeutic applications of monoclonal antibodies. Pharmacol Res Perspect 7(6):e00535. https:\/\/doi.org\/10.1002\/prp2.535","DOI":"10.1002\/prp2.535"},{"key":"669_CR7","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.coche.2018.10.006","volume":"22","author":"C Chen","year":"2018","unstructured":"Chen C, Wong HE, Goudar CT (2018) Upstream process intensification and continuous manufacturing. Curr Opin Chem Eng 22:191\u2013198. https:\/\/doi.org\/10.1016\/j.coche.2018.10.006","journal-title":"Curr Opin Chem Eng"},{"issue":"11","key":"669_CR8","doi-asserted-by":"publisher","first-page":"5007","DOI":"10.1007\/s00253-016-7348-4","volume":"100","author":"T Fu","year":"2016","unstructured":"Fu T, Zhang C, Jing Y, Jiang C, Li Z, Wang S, Ma K, Zhang D, Hou S, Dai J, Kou G, Wang H (2016) Regulation of cell growth and apoptosis through lactate dehydrogenase C over-expression in Chinese hamster ovary cells. Appl Microbiol Biotechnol 100(11):5007\u20135016. https:\/\/doi.org\/10.1007\/s00253-016-7348-4","journal-title":"Appl Microbiol Biotechnol"},{"issue":"7","key":"669_CR9","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/bit.23075","volume":"108","author":"MJ Gramer","year":"2011","unstructured":"Gramer MJ, Eckblad JJ, Donahue R, Brown J, Shultz C, Vickerman K, Priem P, van den Bremer ET, Gerritsen J, van Berkel PH (2011) Modulation of antibody galactosylation through feeding of uridine, manganese chloride, and galactose. Biotechnol Bioeng 108(7):1591\u20131602. https:\/\/doi.org\/10.1002\/bit.23075","journal-title":"Biotechnol Bioeng"},{"key":"669_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.tibtech.2018.05.014","volume":"37","author":"AL Grilo","year":"2019","unstructured":"Grilo AL, Mantalaris A (2019) The increasingly human and profitable monoclonal antibody market. Tr Biotechnol 37:9\u201316. https:\/\/doi.org\/10.1016\/j.tibtech.2018.05.014","journal-title":"Tr Biotechnol"},{"issue":"4","key":"669_CR11","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3390\/bioengineering1040188","volume":"1","author":"P Gronemeyer","year":"2014","unstructured":"Gronemeyer P, Ditz R, Strube J (2014) Trends in upstream and downstream process development for antibody manufacturing. Bioeng 1(4):188\u2013212. https:\/\/doi.org\/10.3390\/bioengineering1040188","journal-title":"Bioeng"},{"key":"669_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.biotechadv.2021.107831","volume":"54","author":"TK Ha","year":"2022","unstructured":"Ha TK, Kim D, Kim CL, Grav LM, Lee GM (2022) Factors affecting the quality of therapeutic proteins in recombinant Chinese hamster ovary cell culture. Biotechnol Adv 54:107831. https:\/\/doi.org\/10.1016\/j.biotechadv.2021.107831","journal-title":"Biotechnol Adv"},{"issue":"1","key":"669_CR13","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/bit.26460","volume":"115","author":"MW Handlogten","year":"2018","unstructured":"Handlogten MW, Lee-O\u2019Brien A, Roy G, Levitskaya SV, Venkat R, Singh S, Ahuja S (2018) Intracellular response to process optimization and impact on productivity and product aggregates for a high-titer CHO cell process. Biotechnol Bioeng 115(1):126\u2013138. https:\/\/doi.org\/10.1002\/bit.26460","journal-title":"Biotechnol Bioeng"},{"issue":"3","key":"669_CR14","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1002\/btpr.1887","volume":"30","author":"V Hecht","year":"2014","unstructured":"Hecht V, Duvar S, Ziehr H, Burg J, Jockwer A (2014) Efficiency improvement of an antibody production process by increasing the inoculum density. Biotechnol Prog 30(3):607\u2013615. https:\/\/doi.org\/10.1002\/btpr.1887","journal-title":"Biotechnol Prog"},{"issue":"6","key":"669_CR15","first-page":"328","volume":"97","author":"T Horiuchi","year":"2019","unstructured":"Horiuchi T (2019) Establishment of a novel CHO cell line and its application to the production of protein-based pharmaceuticals. Seibutsu-Kogaku Kaishi 97(6):328\u2013330 (in Japanese)","journal-title":"Seibutsu-Kogaku Kaishi"},{"issue":"5","key":"669_CR16","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1002\/btpr.436","volume":"26","author":"YM Huang","year":"2010","unstructured":"Huang YM, Hu W, Rustandi E, Chang K, Yusuf-Makagiansar H, Ryll T (2010) Maximizing productivity of CHO cell-based fed-batch culture using chemically defined media conditions and typical manufacturing equipment. Biotechnol Prog 26(5):1400\u20131410. https:\/\/doi.org\/10.1002\/btpr.436","journal-title":"Biotechnol Prog"},{"key":"669_CR17","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.coche.2018.1L","volume":"22","author":"M Jordan","year":"2018","unstructured":"Jordan M, Mac Kinnon N, Monchois V et al (2018) Intensification of large-scale cell culture processes. Curr Opin Chem Eng 22:253\u2013257. https:\/\/doi.org\/10.1016\/j.coche.2018.1L","journal-title":"Curr Opin Chem Eng"},{"key":"669_CR18","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.jbiosc.2017.11.002","volume":"125","author":"Y Kamachi","year":"2018","unstructured":"Kamachi Y, Omasa T (2018) Development of hyper osmotic resistant CHO host cells for enhanced antibody production. J Biosci Bioeng 125:470\u2013478. https:\/\/doi.org\/10.1016\/j.jbiosc.2017.11.002","journal-title":"J Biosci Bioeng"},{"key":"669_CR19","doi-asserted-by":"publisher","first-page":"1860476","DOI":"10.1080\/19420862.2020.1860476","volume":"13","author":"H Kaplon","year":"2021","unstructured":"Kaplon H, Reichert JM (2021) Antibodies to watch in 2021. Mabs 13:1860476. https:\/\/doi.org\/10.1080\/19420862.2020.1860476","journal-title":"Mabs"},{"key":"669_CR20","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/s41587-020-0512-5","volume":"38","author":"B Kelley","year":"2020","unstructured":"Kelley B (2020) Developing therapeutic monoclonal antibodies at pandemic pace. Nat Biotechnol 38:540\u2013545. https:\/\/doi.org\/10.1038\/s41587-020-0512-5","journal-title":"Nat Biotechnol"},{"issue":"13","key":"669_CR21","doi-asserted-by":"publisher","first-page":"e00182","DOI":"10.1016\/j.mec.2021.e00182","volume":"6","author":"B Kuang","year":"2021","unstructured":"Kuang B, Dhara VG, Hoang D, Jenkins J, Ladiwala P, Tan Y, Shaffer SA, Galbraith SC, Betenbaugh MJ, Yoon S (2021) Identification of novel inhibitory metabolites and impact verification on growth and protein synthesis in mammalian cells. Metab Eng Commun 6(13):e00182. https:\/\/doi.org\/10.1016\/j.mec.2021.e00182","journal-title":"Metab Eng Commun"},{"key":"669_CR22","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1007\/s10616-017-0185-1","volume":"70","author":"S Kuwae","year":"2018","unstructured":"Kuwae S, Miyakawa I, Doi T (2018) Development of a chemically defined platform fed-batch culture media for monoclonal antibody-producing CHO cell lines with optimized choline content. Cytotechnol 70:939\u2013948. https:\/\/doi.org\/10.1007\/s10616-017-0185-1","journal-title":"Cytotechnol"},{"issue":"2\u20133","key":"669_CR23","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jbiotec.2012.08.021","volume":"162","author":"H Le","year":"2012","unstructured":"Le H, Kabbur S, Pollastrini L, Sun Z, Mills K, Johnson K, Karypis G, Hu WS (2012) Multivariate analysis of cell culture bioprocess data\u2013lactate consumption as process indicator. J Biotechnol 162(2\u20133):210\u2013223. https:\/\/doi.org\/10.1016\/j.jbiotec.2012.08.021","journal-title":"J Biotechnol"},{"issue":"5","key":"669_CR24","doi-asserted-by":"publisher","first-page":"466","DOI":"10.4161\/mabs.2.5.12720","volume":"2","author":"F Li","year":"2010","unstructured":"Li F, Vijayasankaran N, Shen AY, Kiss R, Amanullah A (2010) Cell culture processes for monoclonal antibody production. Mabs 2(5):466\u2013479. https:\/\/doi.org\/10.4161\/mabs.2.5.12720","journal-title":"Mabs"},{"issue":"2","key":"669_CR25","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1080\/19420862.2018.1527665","volume":"11","author":"S Loebrich","year":"2019","unstructured":"Loebrich S, Clark E, Ladd K, Takahashi S, Brousseau A, Kitchener S, Herbst R, Ryll T (2019) Comprehensive manipulation of glycosylation profiles across development scales. Mabs 11(2):335\u2013349. https:\/\/doi.org\/10.1080\/19420862.2018.1527665","journal-title":"Mabs"},{"issue":"1","key":"669_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12929-019-0592-z","volume":"27","author":"RM Lu","year":"2020","unstructured":"Lu RM, Hwang YC, Liu IJ, Lee CC, Tsai HZ, Li HJ, Wu HC (2020) Development of therapeutic antibodies for the treatment of diseases. J Biomed Sci 27(1):1. https:\/\/doi.org\/10.1186\/s12929-019-0592-z","journal-title":"J Biomed Sci"},{"issue":"1","key":"669_CR27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11095-023-03628-4","volume":"41","author":"S Luo","year":"2024","unstructured":"Luo S, Zhang B (2024) Benchmark glycan profile of therapeutic monoclonal antibodies produced by mammalian cell expression systems. Pharm Res 41(1):29\u201337. https:\/\/doi.org\/10.1007\/s11095-023-03628-4","journal-title":"Pharm Res"},{"issue":"1","key":"669_CR28","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/bit.23291","volume":"109","author":"J Luo","year":"2012","unstructured":"Luo J, Vijayasankaran N, Autsen J, Santuray R, Hudson T, Amanullah A, Li F (2012) Comparative metabolite analysis to understand lactate metabolism shift in Chinese hamster ovary cell culture process. Biotechnol Bioeng 109(1):146\u2013156. https:\/\/doi.org\/10.1002\/bit.23291","journal-title":"Biotechnol Bioeng"},{"issue":"2","key":"669_CR29","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s00449-021-02657-w","volume":"45","author":"A Mah\u00e9","year":"2022","unstructured":"Mah\u00e9 A, Martin\u00e9 A, Fag\u00e8te S, Girod PA (2022) Exploring the limits of conventional small-scale CHO fed-batch for accelerated on demand monoclonal antibody production. Bioprocess Biosyst Eng 45(2):297\u2013307. https:\/\/doi.org\/10.1007\/s00449-021-02657-w","journal-title":"Bioprocess Biosyst Eng"},{"key":"669_CR30","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.jbiosc.2024.02.005","volume":"137","author":"K Masuda","year":"2024","unstructured":"Masuda K, Kubota M, Nakazawa Y, Iwama C, Watanabe K, Ishikawa N, Tanabe Y, Kono S, Tanemura H, Takahashi S, Makino T, Okumura T, Horiuchi T, Nonaka K, Murakami S, Kamihira M, Omasa T (2024) Establishment of a novel cell line, CHO-MK, derived from Chinese hamster ovary tissues for biologics manufacturing. J Biosci Bioeng 137:471\u2013479. https:\/\/doi.org\/10.1016\/j.jbiosc.2024.02.005","journal-title":"J Biosci Bioeng"},{"issue":"1","key":"669_CR31","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s13238-017-0433-3","volume":"9","author":"Y Mimura","year":"2018","unstructured":"Mimura Y, Katoh T, Saldova R, O\u2019Flaherty R, Izumi T, Mimura-Kimura Y, Utsunomiya T, Mizukami Y, Yamamoto K, Matsumoto T, Rudd PM (2018) Glycosylation engineering of therapeutic IgG antibodies: challenges for the safety, functionality and efficacy. Protein Cell 9(1):47\u201362. https:\/\/doi.org\/10.1007\/s13238-017-0433-3","journal-title":"Protein Cell"},{"issue":"8","key":"669_CR32","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1002\/bit.26313","volume":"114","author":"BC Mulukutla","year":"2017","unstructured":"Mulukutla BC, Kale J, Kalomeris T, Jacobs M, Hiller GW (2017) Identification and control of novel growth inhibitors in fed-batch cultures of Chinese hamster ovary cells. Biotechnol Bioeng 114(8):1779\u20131790. https:\/\/doi.org\/10.1002\/bit.26313","journal-title":"Biotechnol Bioeng"},{"key":"669_CR33","doi-asserted-by":"publisher","first-page":"107552","DOI":"10.1016\/j.biotechadv.2020.107552","volume":"43","author":"R O\u2019Flaherty","year":"2020","unstructured":"O\u2019Flaherty R, Bergin A, Flampouri E, Mota LM, Obaidi I, Quigley A, Xie Y, Butler M (2020) Mammalian cell culture for production of recombinant proteins: a review of the critical steps in their biomanufacturing. Biotechnol Adv 43:107552. https:\/\/doi.org\/10.1016\/j.biotechadv.2020.107552","journal-title":"Biotechnol Adv"},{"key":"669_CR34","unstructured":"Omasa T, Yamano N (2018) Newly established cell lines derived from Chinese hamster for production of biologics. Cell Culture Engineering XVI. https:\/\/dc.engconfintl.org\/ccexvi\/177"},{"issue":"3","key":"669_CR35","doi-asserted-by":"publisher","first-page":"e1700499","DOI":"10.1002\/biot.201700499","volume":"13","author":"S Pereira","year":"2018","unstructured":"Pereira S, Kildegaard HF, Andersen MR (2018) Impact of CHO metabolism on cell growth and protein production: an overview of toxic and inhibiting metabolites and nutrients. Biotechnol J 13(3):e1700499. https:\/\/doi.org\/10.1002\/biot.201700499","journal-title":"Biotechnol J"},{"issue":"1","key":"669_CR36","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/btpr.1672","volume":"29","author":"M Pohlscheidt","year":"2013","unstructured":"Pohlscheidt M, Jacobs M, Wolf S, Thiele J, Jockwer A, Gabelsberger J, Jenzsch M, Tebbe H, Burg J (2013) Optimizing capacity utilization by large scale 3000 L perfusion in seed train bioreactors. Biotechnol Prog 29(1):222\u2013229. https:\/\/doi.org\/10.1002\/btpr.1672","journal-title":"Biotechnol Prog"},{"key":"669_CR37","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/bit.24608","volume":"110","author":"J Pollock","year":"2013","unstructured":"Pollock J, Ho SV, Farid SS (2013) Fed-batch and perfusion culture processes: economic, environmental, and operational feasibility under uncertainty. Biotechnol Bioeng 110:206\u2013219. https:\/\/doi.org\/10.1002\/bit.24608","journal-title":"Biotechnol Bioeng"},{"issue":"6","key":"669_CR38","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1084\/jem.108.6.945","volume":"108","author":"TT Puck","year":"1958","unstructured":"Puck TT, Cieciura SJ, Robinson A (1958) Genetics of somatic mammalian cells. III. Long-term cultivation of euploid cells from human and animal subjects. J Exp Med 108(6):945\u2013956. https:\/\/doi.org\/10.1084\/jem.108.6.945","journal-title":"J Exp Med"},{"issue":"3","key":"669_CR39","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1007\/s00253-018-9555-7","volume":"103","author":"J Qin","year":"2019","unstructured":"Qin J, Wu X, Xia Z, Huang Z, Zhang Y, Wang Y, Fu Q, Zheng C (2019) The effect of hyperosmolality application time on production, quality, and biopotency of monoclonal antibodies produced in CHO cell fed-batch and perfusion cultures. Appl Microbiol Biotechnol 103(3):1217\u20131229. https:\/\/doi.org\/10.1007\/s00253-018-9555-7","journal-title":"Appl Microbiol Biotechnol"},{"issue":"1","key":"669_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/antib7010001","volume":"7","author":"D Radhakrishnan","year":"2017","unstructured":"Radhakrishnan D, Robinson AS, Ogunnaike BA (2017) Controlling the glycosylation profile in mAbs using time-dependent media supplementation. Antibodies (Basel) 7(1):1. https:\/\/doi.org\/10.3390\/antib7010001","journal-title":"Antibodies (Basel)"},{"issue":"4","key":"669_CR41","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s10529-011-0809-z","volume":"34","author":"Y Rajendra","year":"2012","unstructured":"Rajendra Y, Kiseljak D, Baldi L, Hacker DL, Wurm FM (2012) Reduced glutamine concentration improves protein production in growth-arrested CHO-DG44 and HEK-293E cells. Biotechnol Lett 34(4):619\u2013626. https:\/\/doi.org\/10.1007\/s10529-011-0809-z","journal-title":"Biotechnol Lett"},{"issue":"11","key":"669_CR42","doi-asserted-by":"publisher","first-page":"4645","DOI":"10.1007\/s00253-015-6514-4","volume":"99","author":"D Reinhart","year":"2015","unstructured":"Reinhart D, Damjanovic L, Kaisermayer C, Kunert R (2015) Benchmarking of commercially available CHO cell culture media for antibody production. Appl Microbiol Biotechnol 99(11):4645\u20134657. https:\/\/doi.org\/10.1007\/s00253-015-6514-4","journal-title":"Appl Microbiol Biotechnol"},{"issue":"1","key":"669_CR43","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s10616-022-00561-z","volume":"75","author":"M Saldanha","year":"2023","unstructured":"Saldanha M, Shelar A, Patil V, Warke VG, Dandekar P, Jain R (2023) A case study: correlation of the nutrient composition in Chinese Hamster Ovary cultures with cell growth, antibody titre and quality attributes using multivariate analyses for guiding medium and feed optimization in early upstream process development. Cytotechnol 75(1):77\u201391. https:\/\/doi.org\/10.1007\/s10616-022-00561-z","journal-title":"Cytotechnol"},{"key":"669_CR44","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1002\/btpr.1907","volume":"30","author":"Z Sheikholeslami","year":"2014","unstructured":"Sheikholeslami Z, Jolicoeur M, Henry O (2014) Elucidating the effects of postinduction glutamine feeding on the growth and productivity of CHO cells. Biotechnol Prog 30:535\u2013546. https:\/\/doi.org\/10.1002\/btpr.1907","journal-title":"Biotechnol Prog"},{"issue":"10","key":"669_CR45","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1002\/bit.25251","volume":"111","author":"MM St Amand","year":"2014","unstructured":"St Amand MM, Radhakrishnan D, Robinson AS, Ogunnaike BA (2014) Identification of manipulated variables for a glycosylation control strategy. Biotechnol Bioeng 111(10):1957\u20131970. https:\/\/doi.org\/10.1002\/bit.25251","journal-title":"Biotechnol Bioeng"},{"issue":"8","key":"669_CR46","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1007\/s00449-020-02337-1","volume":"43","author":"L Stepper","year":"2020","unstructured":"Stepper L, Filser FA, Fischer S, Schaub J, Gorr I, Voges R (2020) Pre-stage perfusion and ultra-high seeding cell density in CHO fed-batch culture: a case study for process intensification guided by systems biotechnology. Bioprocess Biosyst Eng 43(8):1431\u20131443. https:\/\/doi.org\/10.1007\/s00449-020-02337-1","journal-title":"Bioprocess Biosyst Eng"},{"key":"669_CR47","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s10616-017-0066-7","volume":"69","author":"Y Takagi","year":"2017","unstructured":"Takagi Y, Kikuchi T, Wada R, Omasa T (2017) The enhancement of antibody concentration and achievement of high cell density CHO cell cultivation by adding nucleoside. Cytotechnol 69:511\u2013521. https:\/\/doi.org\/10.1007\/s10616-017-0066-7","journal-title":"Cytotechnol"},{"key":"669_CR48","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ddtec.2021.02.003","volume":"38","author":"B Tihanyi","year":"2020","unstructured":"Tihanyi B, Nyitray L (2020) Recent advances in CHO cell line development for recombinant protein production. Drug Discov Today Technol 38:25\u201334. https:\/\/doi.org\/10.1016\/j.ddtec.2021.02.003","journal-title":"Drug Discov Today Technol"},{"key":"669_CR49","doi-asserted-by":"publisher","unstructured":"Torkashvand F, Vaziri B (2017) Main quality attributes of monoclonal antibodies and effect of cell culture components. Iran Biomed J 21(3):131\u2013141. https:\/\/doi.org\/10.18869\/acadpub.ibj.21.3.131","DOI":"10.18869\/acadpub.ibj.21.3.131"},{"issue":"12","key":"669_CR50","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1038\/s41587-022-01582-x","volume":"40","author":"G Walsh","year":"2022","unstructured":"Walsh G, Walsh E (2022) Biopharmaceutical benchmarks 2022. Nat Biotechnol 40(12):1722\u20131760. https:\/\/doi.org\/10.1038\/s41587-022-01582-x","journal-title":"Nat Biotechnol"},{"key":"669_CR51","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3390\/pr1030296","volume":"1","author":"FM Wurm","year":"2013","unstructured":"Wurm FM (2013) CHO Quasispecies\u2014implications for manufacturing processes. Processes 1:296\u2013311. https:\/\/doi.org\/10.3390\/pr1030296","journal-title":"Processes"},{"key":"669_CR52","doi-asserted-by":"publisher","first-page":"945","DOI":"10.3390\/life11090945","volume":"11","author":"S Xiao","year":"2021","unstructured":"Xiao S, Ahmed W, Mohsin A, Guo M (2021) Continuous feeding reduces the generation of metabolic byproducts and increases antibodies expression in Chinese hamster ovary-K1 cells. Life 11:945. https:\/\/doi.org\/10.3390\/life11090945","journal-title":"Life"},{"key":"669_CR53","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1021\/bp070466m","volume":"24","author":"Z Xing","year":"2008","unstructured":"Xing Z, Li Z, Chow V, Lee SS (2008) Identifying inhibitory threshold values of repressing metabolites in CHO cell culture using multivariate analysis methods. Biotechnol Prog 24:675\u2013683. https:\/\/doi.org\/10.1021\/bp070466m","journal-title":"Biotechnol Prog"},{"key":"669_CR54","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.bej.2017.05.007","volume":"124","author":"N Xu","year":"2017","unstructured":"Xu N, Ma C, Ou J, Sun WW, Zhou L, Hu H, Liu XM (2017a) Comparative proteomic analysis of three Chinese hamster Ovary (CHO) host cells. Biochem Eng J 124:122\u2013129. https:\/\/doi.org\/10.1016\/j.bej.2017.05.007","journal-title":"Biochem Eng J"},{"issue":"4","key":"669_CR55","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1002\/btpr.2415","volume":"33","author":"S Xu","year":"2017","unstructured":"Xu S, Gavin J, Jiang R, Chen H (2017b) Bioreactor productivity and media cost comparison for different intensified cell culture processes. Biotechnol Prog 33(4):867\u2013878. https:\/\/doi.org\/10.1002\/btpr.2415","journal-title":"Biotechnol Prog"},{"issue":"4","key":"669_CR56","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s00253-022-12342-x","volume":"107","author":"WJ Xu","year":"2023","unstructured":"Xu WJ, Lin Y, Mi CL, Pang JY, Wang TY (2023) Progress in fed-batch culture for recombinant protein production in CHO cells. Appl Microbiol Biotechnol 107(4):1063\u20131075. https:\/\/doi.org\/10.1007\/s00253-022-12342-x","journal-title":"Appl Microbiol Biotechnol"},{"issue":"3","key":"669_CR57","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1002\/btpr.1884","volume":"30","author":"WC Yang","year":"2014","unstructured":"Yang WC, Lu J, Kwiatkowski C, Yuan H, Kshirsagar R, Ryll T, Huang YM (2014) Perfusion seed cultures improve biopharmaceutical fed-batch production capacity and product quality. Biotechnol Prog 30(3):616\u2013625. https:\/\/doi.org\/10.1002\/btpr.1884","journal-title":"Biotechnol Prog"},{"issue":"8","key":"669_CR58","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1080\/19420862.2019.1652075","volume":"11","author":"A Yongky","year":"2019","unstructured":"Yongky A, Xu J, Tian J, Oliveira C, Zhao J, McFarland K, Borys MC, Li ZJ (2019) Process intensification in fed-batch production bioreactors using non-perfusion seed cultures. Mabs 11(8):1502\u20131514. https:\/\/doi.org\/10.1080\/19420862.2019.1652075","journal-title":"Mabs"},{"issue":"5","key":"669_CR59","doi-asserted-by":"publisher","first-page":"e3186","DOI":"10.1002\/btpr.3186","volume":"37","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Chen J, Wang J, Gao Q, Ma Z, Xu S, Zhang L, Cai J, Zhou W (2021) Reshaping cell line development and CMC strategy for fast responses to pandemic outbreak. Biotechnol Prog 37(5):e3186. https:\/\/doi.org\/10.1002\/btpr.3186","journal-title":"Biotechnol Prog"},{"key":"669_CR60","doi-asserted-by":"publisher","first-page":"856049","DOI":"10.3389\/fbioe.2022.856049","volume":"10","author":"JH Zhang","year":"2022","unstructured":"Zhang JH, Shan LL, Liang F, Du CY, Li JJ (2022) Strategies and considerations for improving recombinant antibody production and quality in Chinese hamster ovary cells. Front Bioeng Biotechnol 10:856049. https:\/\/doi.org\/10.3389\/fbioe.2022.856049","journal-title":"Front Bioeng Biotechnol"},{"key":"669_CR61","doi-asserted-by":"publisher","first-page":"568","DOI":"10.4161\/mabs.3.6.17922","volume":"3","author":"K Zheng","year":"2011","unstructured":"Zheng K, Bantog C, Bayer R (2011) The impact of glycosylation on monoclonal antibody conformation and stability. Mabs 3:568\u2013576. https:\/\/doi.org\/10.4161\/mabs.3.6.17922","journal-title":"Mabs"},{"key":"669_CR62","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1007\/978-3-319-52287-6_29","volume":"3","author":"MM Zhu","year":"2017","unstructured":"Zhu MM, Mollet M, Hubert RS, Kyung YS, Zhang GG (2017) Industrial production of therapeutic proteins: Cell lines, cell culture, and purification. Handbook  Ind Chem Biotechnol 3:1639\u20131669. https:\/\/doi.org\/10.1007\/978-3-319-52287-6_29","journal-title":"Handbook Ind Chem Biotechnol"}],"container-title":["Cytotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10616-024-00669-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10616-024-00669-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10616-024-00669-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T02:29:21Z","timestamp":1741228161000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10616-024-00669-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,18]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["669"],"URL":"https:\/\/doi.org\/10.1007\/s10616-024-00669-4","relation":{},"ISSN":["0920-9069","1573-0778"],"issn-type":[{"value":"0920-9069","type":"print"},{"value":"1573-0778","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,18]]},"assertion":[{"value":"19 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"1"}}